Lentiviral vectors are among the most effective viral vectors for vaccination. In clear contrast
to the reference adenoviral vectors, lentiviral vectors have a high potential for transducing …

Influenza virus and severe acute respiratory syndrome coronavirus (SARS-CoV-2) have
caused respiratory diseases worldwide. Coronavirus disease 2019 (COVID-19) is now a …

Background Although recent epidemiological data suggest that pneumococci may contribute
to the risk of SARS-CoV-2 disease, cases of coinfection with Streptococcus pneumoniae in …

Inhalation of tobacco smoke has been linked to increased risk of viral infection, such as
influenza. Inhalation of electronic-cigarette (e-cigarette) aerosol has also recently been …

Naegleria fowleri is an etiological agent that generates primary amoebic
meningoencephalitis; unfortunately, no effective treatment or vaccine is available. The …

Background We previously demonstrated that an intranasal dose of 108 50% tissue culture
infectious dose (TCID50) M2-deficient single replication (M2SR) influenza vaccine protected …

Secretory immunoglobulin A (sIgA) in saliva is the most important immunoglobulin fighting
pathogens in the respiratory tract and may thus play a role in preventing SARS-CoV-2 …

Despite the availability of vaccines that efficiently reduce the severity of clinical symptoms,
influenza viruses still cause substantial morbidity and mortality worldwide. In this regard …

Annual vaccination is the best prevention of influenza. However, the immunogenicity of
influenza vaccines varies among different populations. It is important to fully identify the …

Influenza viral infection poses a severe risk to global public health. Considering the
suboptimal protection provided by current influenza vaccines against circulating influenza A …